Talk to our breast care nurses
0808 800 6000
The National Institute for Health and Care Excellence (NICE) has today (3 October 2019) announced its decision to provisionally reject immunotherapy...
The study followed 47,000 women in Sweden between the ages of 29 and 49 over 20 years, with 1,500 of them developing breast or bowel cancer. The...
8 February 2019 New research from Stanford University has found that high levels of CD24 found on the surface of cancer cells can stop immune...
31 July 2019 The Scottish Government has announced that a review of the Scottish Breast Screening Programme is to be carried out....
17 July 2019 The National Institute for Health and Care Excellence (NICE) has today (17 July 2019) announced its decision to approve ribociclib...
The National Institute for Health and Care Excellence (NICE) has today (17 July 2019) announced its decision to approve ribociclib in combination...
8 July 2019 The Scottish Medicines Consortium (SMC) has today (8 July 2019) announced its decision to approve palbociclib in combination with...
3 June 2019 The new Interim NHS People Plan was launched on Monday 3 June 2019 to address the workforce challenges the health service is...
Ribociclib (Kisqali, Novartis) is one of a class of drugs known as CDK4/6 inhibitors, which have recently been introduced to NHS care and work by...
Stay in touch
We’d love to keep in touch about news, events and how you can get involved. To hear from us, enter your email address below.
Connect with us
